INVO Fertility (IVF) Depreciation & Amortization (CF) (2011 - 2026)

INVO Fertility (IVF) has 16 years of Depreciation & Amortization (CF) data on file, last reported at $142698.0 in Q1 2026.

• On a quarterly basis, Depreciation & Amortization (CF) fell 39.14% year-over-year to $142698.0 in Q1 2026; TTM through Mar 2026 was $449175.0, a 51.55% decrease from a year earlier, with the FY2024 full-year figure at $919603.0, up 357.76% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $142698.0, up from $136741.0 in the prior quarter.
• Over the last five years, Depreciation & Amortization (CF) for IVF reached as high as $234462.0 in Q1 2025 and fell as low as $15547.0 in Q1 2022.
• Historically, Depreciation & Amortization (CF) has averaged $117589.7 across 5 years, with a median of $139169.5 in 2023.
• Across the five-year window, Depreciation & Amortization (CF) soared 1089.08% in 2024 and tumbled 40.68% in 2025, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $19940.0 in 2022, then soared by 610.12% to $141598.0 in 2023, then soared by 63.71% to $231810.0 in 2024, then plunged by 41.01% to $136741.0 in 2025, then gained by 4.36% to $142698.0 in 2026.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $142698.0 in Q1 2026, $136741.0 in Q3 2025, and $169736.0 in Q2 2025.